From: Clinical aspects of TP53 gene inactivation in diffuse large B-cell lymphoma
Mutation | Functional prediction | Activity of p53 protein in experiment in vitro [reference] | ||
---|---|---|---|---|
PolyÐ hen-2 (description of mutation) | SIFT (description of mutation) | Mut_ass (degree of pathogenicity) | ||
p.L130F | Probably pathogenic | Dangerous | High | Not active [44] |
p.W146R | Non-pathogenic | Neutral | Low | Slightly reduced [44] |
p.T155I | Probably pathogenic | Dangerous | Moderate | |
p.R156C | Non-pathogenic | Neutral | Low | |
p.R196Q | Probably pathogenic | Dangerous | High | Not active [38] |
p.G244S | Probably pathogenic | Dangerous | Moderate | |
p.V272E | Probably pathogenic | Dangerous | High | Not active [44] |
p.A276V | Probably pathogenic | Dangerous | Moderate | Not active [46] |
p.G293R | Non-pathogenic | Neutral | Moderate | Slightly reduced [44] |
p.A276V | Probably pathogenic | Dangerous | Moderate | Not active [38] |
p.G293R | Non-pathogenic | Neutral | Moderate | Slightly reduced [44] |